Pharma patents - the Commission's interim report @ UCL
It’s not too late to sign up for UCL Institute of Brand an Innovation Law’s seminar (developed in co-operation with Lord Justice Jacob) next Wednesday, ‘Patent practices in the pharmaceutical sector – the aftermath of the European Commission’s interim report’.
- Paul Denerley - AstraZeneca
- Ann Nielson - Bristol-Myers Squibb
- David Rosenberg - GSK
- Howard Rosenberg - Frommer, Lawrence and Haug LLP
- John Kallaugher - UCL & Lathan & Watkins
The event is free, and kicks off at 5pm for a 5.15 start – you can sign up here.
Psychics stare into their footballs
It seems that Trade Mark Registry watchers have found a new use for their sport. Not content with predicting the latest extension of the Apple brand by watching out for marks in the form ‘iProduct’, they now are using their amazing mystical powers to predict the footballing future. In seems that one Mr Cristiano Ronaldo Dos Santos Aveiro, of
What puzzles the IPKat is that the application is for Class 43 ‘Services for providing food and drink; temporary and hotel accommodation’. Merpel wants to know, will C3PO be mounting an opposition claim?
'Return to sender' says Australian hearing officer
The IPKat was glad to read that Elvis Jelcic has succeeded in his Australian application to register ElvisFinance as a trade mark for financial services. Mr Jelcic’s application was opposed by Elvis Presley Enterprises, seemingly because consumers might believe that the business was endorsed by the late Mr Presley. According to the hearing officer:
The use only of the name Elvis next to the word FINANCE is not enough to cause a likelihood of deception or confusion. If the applicant were to embellish the mark with anything that would suggest Mr. Presley, such as guitars, the word King, white jump suits or suchlike, then the opponent might have remedies in another jurisdiction. However, I find that this ground of opposition is not established.
The IPKat is happy on two counts. What consumer would really think that the late rock ‘n’ roller would endorse financial services? Even the idea of his estate endorsing them seems unlikely – the link between a dead celebrity singer and finance is tenuous in the extreme. Secondly, Elvis is the applicant’s name (though technically, in the UK at least, this wouldn’t prevent an opposition) and is a ‘standard’ first name.